Cargando…
A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA
Cancer is the leading cause of death worldwide. Tumors consist of heterogeneous cell populations that have different biological properties. While conventional cancer therapy such as chemotherapy, radiotherapy, and surgery does not target cancer cells specifically, gene therapy is attracting increasi...
Autores principales: | Toma, Ioana, Porfire, Alina Silvia, Tefas, Lucia Ruxandra, Berindan-Neagoe, Ioana, Tomuță, Ioan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322860/ https://www.ncbi.nlm.nih.gov/pubmed/35890377 http://dx.doi.org/10.3390/pharmaceutics14071482 |
Ejemplares similares
-
Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach
por: Tefas, Lucia Ruxandra, et al.
Publicado: (2017) -
Development of a Curcumin-Loaded Polymeric Microparticulate Oral Drug Delivery System for Colon Targeting by Quality-by-Design Approach
por: Hales, Dana, et al.
Publicado: (2020) -
Curcumin-Loaded Microspheres Are Effective in Preventing Oxidative Stress and Intestinal Inflammatory Abnormalities in Experimental Ulcerative Colitis in Rats
por: Hales, Dana, et al.
Publicado: (2022) -
Statins in risk-reduction and treatment of cancer
por: Barbalata, Cristina I, et al.
Publicado: (2020) -
Salinomycin-Based Drug Delivery Systems: Overcoming the Hurdles in Cancer Therapy
por: Tefas, Lucia Ruxandra, et al.
Publicado: (2021)